Brian D. Bewley Partner

Brian represents healthcare and life sciences companies, private equity sponsors, and portfolio companies on regulatory compliance, enforcement risk, and strategic issues that shape transactions, operations, and enterprise value.

Brian guides a broad range of healthcare and life sciences industry participants including fortune 100 companies, pharmaceutical and medical device manufacturers, hospitals and health systems, digital health and digital therapeutics companies, specialty pharmacies, managed care organizations, long-term care providers, and durable medical equipment suppliers through compliance challenges, investigations, transactions, and high-stakes enforcement matters.

Brian partners with private equity sponsors and their portfolio companies across the full investment cycle, helping sponsors protect and maximize the value of their investments. He guides sponsors and portfolio companies through each phase of the investment from platform formation, structuring, pre-closing diligence and remediation, add-ons, required regulatory approvals at entry, operational integration, compliance infrastructure, internal investigations, responses to government inquiries during the hold period, to reverse diligence, exit preparation, and sale-side representation at exit. Brian’s compliance and regulatory work spans the Stark Law, Anti-Kickback Statute, False Claims Act, and many other state and federal regulatory laws.

Drawing on significant government enforcement experience, Brian develops winning strategies on enforcement matters, overpayment disputes, self-disclosure matters, and parallel government investigations. His results include multiple DOJ declinations and client-friendly resolutions, including the reduction of an $8 million Medicare overpayment determination to under $400,000, with the government returning roughly $500,000 in interest to the provider, and a negotiated HHS OIG resolution for a private equity sponsor and portfolio company that came in nearly $10 million below the government’s original demand.

In addition to his client work, Brian frequently speaks on healthcare enforcement trends, private equity investment strategies and risk mitigation, and regulatory developments affecting the healthcare and life sciences industries. His insights have been featured in PE Hub, Politico, and Bloomberg Law, and he was recognized on the Thomson Reuters Stand-Out Lawyers list (2025–2026), a distinction based on feedback from in-house counsel.

Prior to private practice, Brian served as senior counsel and team leader at HHS OIG where he oversaw enforcement matters nationwide, including overseeing the Miami, Dallas, Boston, and San Francisco regional offices. He was selected for the DOJ Attorney General’s Honors Program and served as a special assistant U.S. attorney during his time in the government, leading matters involving alleged Medicare and Medicaid fraud, False Claims Act liability, Anti-Kickback Statute, and Stark Law issues.

Prior to law school, Brian served as a U.S. Peace Corps volunteer in a remote village of Burkina Faso, West Africa, where he taught the sciences in French – an experience that continues to shape how he approaches complex problems and strategic solutions for clients.